Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Dec. 7, 2017. Erik Vollebregt.

Executive Summary

Check out what attorney Erik Vollebregt had to say about the threat of device companies losing their current notified body as the EU transitions to its new Medical Device and IVD Regulations.

"As a company, you have to create a situation where if you are dumped, the quality of your dossiers is such that you have the best chances to be recertified quickly by another notified body – which means that you have to make sure everything is state-of-the-art." – Erik Vollebregt, partner, Axon Lawyers

> Find out more: Expert Panel: How Manufacturers Are Paying For Notified Body Struggles

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121883

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel